Ikuo Masuho1, Mingyan Fang1, Chunyu Geng1, Jianguo Zhang1, Hui Jiang1, Riza Köksal Özgul1, Didem Yücel Yılmaz1, Dilek Yalnızoğlu1, Deniz Yüksel1, Anna Yarrow1, Angela Myers1, Sabrina C Burn1, Patricia L Crotwell1, Sergio Padilla-Lopez1, Ali Dursun1, Kirill A Martemyanov1, Michael C Kruer1. 1. Department of Neuroscience (I.M., K.A.M.), Scripps Research Institute, Jupiter, FL; Shenzhen Key Laboratory of Neurogenomics (M.F., J.Z.), BGI-Shenzhen (M.F., C.G., J.Z., H.J.), Shenzhen, China; Department of Pediatric Metabolism (R.K.Ö., D.Y.Y., A.D.), Institute of Child Health; Department of Pediatric Neurology (D. Yalnızoğlu), Faculty of Medicine, Hacettepe University, Ankara, Turkey; Department of Pediatric Neurology (D. Yüksel), Dr. Sami Ulus Maternity and Children's Research and Training Hospital, Ministry of Health, Ankara, Turkey; Sanford Children's Health Research Center (A.Y., A.M., S.C.B., P.L.C.), Sioux Falls, SD; Department of Child Health (S.P.-L., M.C.K.), University of Arizona College of Medicine, Phoenix, AZ; Movement Disorders Center and Neurogenetics Research Program (S.P.-L., M.C.K.), Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ; and Program in Neuroscience (M.C.K.), Arizona State University, Tempe, AZ.
Heterozygous loss-of-function mutations in the GNAL gene encoding the α subunit of the heterotrimeric G protein Golf (Gαolf) are known to cause isolated dystonia.[1,2] Gαolf is enriched in the striatum where it couples D1 dopamine (D1R) and A2A adenosine (A2AR) receptors to the activation of adenylyl cyclase type 5 (AC5). Mutations in ADCY5, the gene encoding AC5, are also known to lead to chorea and dystonia.[3,4] Previous functional studies of mutated Gαolf variants have revealed deficiencies in activation after D1R stimulation.[1,5]Patients with heterozygous GNAL mutations typically exhibit an adult-onset focal cervical, laryngeal, and/or segmental dystonia.[2] Such cases are typically either familial autosomal dominant or sporadic, resulting from de novo mutations. We describe a multiplex consanguineous Turkish family in which 2 affected children exhibited childhood-onset generalized dystonia. Affected patients were found to harbor a homozygous missense mutation in GNAL, representing biallelic mutations rather than the heterozygous GNAL mutations typically encountered.We enrolled the patients in our ethics and institutional review board–approved research study after obtaining written informed consent. The index patient was born at term without complications. The mother took no medications during her pregnancy. Growth and early milestones were attained on time. The girl's parents first became concerned at age 1 year when she began to show evidence of exaggerated muscle tone. As the girl grew older, generalized dystonia affecting the head/neck, trunk, and limbs emerged. She experienced academic difficulties upon starting school, and was diagnosed with mild intellectual disability. At age 15 years, she exhibited generalized dystonia and impaired volitional movement. She experienced action-induced spasms and exacerbations of her baseline dystonia. Laboratory workup was unrevealing and her neuroimaging was unremarkable.The girl's younger sister was also born at term without complications or prenatal exposures. She too met early motor and language milestones within the first year, but was noted to have hypertonia at age 1 year. She also lagged behind her peers in school and was diagnosed with mild intellectual disability. At age 11 years, she showed generalized dystonia that interfered with purposeful movements, with distressing dystonic spasms. Laboratory evaluations were nondiagnostic, and MRI of the brain was normal for age.Given the family structure, we suspected an autosomal recessive disorder with identity by descent. Because autosomal recessive dystonia mutations have only recently been described,[6] we began our studies suspecting a novel gene. We applied an approach of tandem homozygosity mapping and whole exome sequencing.We identified 5 blocks of homozygosity ≥3 Mb shared by the affected sisters but absent from unaffected siblings. Whole exome sequencing was performed using the Complete Genomics platform (appendix e-1 at Neurology.org/ng), and revealed a novel homozygous c.1216C>T (p.R329W) missense variant in GNAL (NM_182978) within a prominent block of homozygosity on chromosome 18 (hg19; chr18:7,490,028-15,143,714). This variant was predicted to be deleterious across several algorithms (SIFT, PolyPhen-2, MutationTaster, and PhyloP) and affects a residue that is highly conserved across species. This variant was not observed in the Exome Variant Server and ExAc Browser databases, and segregated in a homozygous form with affected status in the family (figure, A). Both parents and several siblings were heterozygous but did not display any overt dystonia.
Figure
GNAL mutation and functional characterization
(A) Family pedigrees. Filled symbols correspond to affected individuals. Empty symbols represent healthy individuals. Electropherograms show the missense mutation that leads to the (p.R293W) variant of GNAL. (B). Schematic of Gαolf functional coupling to D1R and bioluminescence resonance energy transfer (BRET) assay. Stimulation of the D1R by dopamine results in the dissociation of Gαolf from the heterotrimer. Released Gβγ subunits tagged with Venus become available for interaction with Nluc-tagged GRK reporter producing the BRET signal, which is determined by the change in the emission ratio at wavelengths 535 and 480 nm. (C) Time course. BRET signal changes upon stimulation of cells with dopamine and subsequent deactivation by haloperidol. (D) BRET ratios. Basal ratios calculated before the application of dopamine reflect the extent of the Gαolf–Gβγ heterotrimer formation, and changes in the BRET ratio from basal signal to maximal response reflect the amplitude of the response. Results represent the mean of quadruplicate wells from a typical experiment. Similar results were seen in 2 independent experiments. Error bars represent the SEM. An unpaired t test was performed to determine statistically significant differences. Asterisks indicate statistical significance from wild-type control: ***p < 0.001.
GNAL mutation and functional characterization
(A) Family pedigrees. Filled symbols correspond to affected individuals. Empty symbols represent healthy individuals. Electropherograms show the missense mutation that leads to the (p.R293W) variant of GNAL. (B). Schematic of Gαolf functional coupling to D1R and bioluminescence resonance energy transfer (BRET) assay. Stimulation of the D1R by dopamine results in the dissociation of Gαolf from the heterotrimer. Released Gβγ subunits tagged with Venus become available for interaction with Nluc-tagged GRK reporter producing the BRET signal, which is determined by the change in the emission ratio at wavelengths 535 and 480 nm. (C) Time course. BRET signal changes upon stimulation of cells with dopamine and subsequent deactivation by haloperidol. (D) BRET ratios. Basal ratios calculated before the application of dopamine reflect the extent of the Gαolf–Gβγ heterotrimer formation, and changes in the BRET ratio from basal signal to maximal response reflect the amplitude of the response. Results represent the mean of quadruplicate wells from a typical experiment. Similar results were seen in 2 independent experiments. Error bars represent the SEM. An unpaired t test was performed to determine statistically significant differences. Asterisks indicate statistical significance from wild-type control: ***p < 0.001.We suspected this missense change to be the probable cause of the patients' phenotype. To test this idea, we evaluated the ability of mutated Gαolf to be activated by the D1R upon reconstitution in HEK293T cells using our previously published bioluminescence resonance energy transfer (BRET) strategy[1] (figure, B). In mutants, the basal BRET ratio is elevated, indicating a marked deficit in Gβγ binding and/or protein stability (figure, C). We further observed a markedly diminished activation of mutated Gαolf in response to D1R stimulation with dopamine (figure, D), indicating an additional partial loss of function.Taken together, these findings suggest that our cases represent bona fide autosomal recessive GNAL-associated disease. The mutation seen in our patients seems to lead primarily to impaired Gαolf functional coupling to dopamine D1 receptors, differing from previously described mutations in GNAL that lead to a strict loss-of-function phenotype.[1,5] It is likely that, although the coupling of Gαolf with dopamine D1 receptors is impaired, enough normal protein is present in heterozygotes to retain the ability to bind the receptor efficiently and maintain adequate biological activity. Thus, only biallelic (p.R329W) mutations impair Gαolf functional coupling enough to cause the observed phenotype. Our findings indicate that mutations in GNAL may manifest through either autosomal dominant or recessive modes of inheritance, with the present patients exhibiting generalized dystonia with onset in childhood.
Authors: Satya R Vemula; Andreas Puschmann; Jianfeng Xiao; Yu Zhao; Monika Rudzińska; Karen P Frei; Daniel D Truong; Zbigniew K Wszolek; Mark S LeDoux Journal: Hum Mol Genet Date: 2013-02-27 Impact factor: 6.150
Authors: Kishore R Kumar; Katja Lohmann; Ikuo Masuho; Ryosuke Miyamoto; Andreas Ferbert; Thora Lohnau; Meike Kasten; Johann Hagenah; Norbert Brüggemann; Julia Graf; Alexander Münchau; Vladimir S Kostic; Carolyn M Sue; Aloysius R Domingo; Raymond L Rosales; Lilian V Lee; Karen Freimann; Ana Westenberger; Youhei Mukai; Toshitaka Kawarai; Ryuji Kaji; Christine Klein; Kirill A Martemyanov; Alexander Schmidt Journal: JAMA Neurol Date: 2014-04 Impact factor: 18.302
Authors: Ying-Zhang Chen; Mark M Matsushita; Peggy Robertson; Mark Rieder; Santhosh Girirajan; Francesca Antonacci; Hillary Lipe; Evan E Eichler; Deborah A Nickerson; Thomas D Bird; Wendy H Raskind Journal: Arch Neurol Date: 2012-05
Authors: Michael Zech; Daniel D Lam; Ludmila Francescatto; Barbara Schormair; Aaro V Salminen; Angela Jochim; Thomas Wieland; Peter Lichtner; Annette Peters; Christian Gieger; Hanns Lochmüller; Tim M Strom; Bernhard Haslinger; Nicholas Katsanis; Juliane Winkelmann Journal: Am J Hum Genet Date: 2015-05-21 Impact factor: 11.025
Authors: Tania Fuchs; Rachel Saunders-Pullman; Ikuo Masuho; Marta San Luciano; Deborah Raymond; Stewart Factor; Anthony E Lang; Tsao-Wei Liang; Richard M Trosch; Sierra White; Edmond Ainehsazan; Denis Hervé; Nutan Sharma; Michelle E Ehrlich; Kirill A Martemyanov; Susan B Bressman; Laurie J Ozelius Journal: Nat Genet Date: 2012-12-09 Impact factor: 38.330
Authors: Mohammad Moshahid Khan; Jianfeng Xiao; T J Hollingsworth; Damini Patel; Dana E Selley; Trevor L Ring; Mark S LeDoux Journal: Exp Neurol Date: 2019-04-26 Impact factor: 5.330
Authors: Hind Baba Aïssa; Romain W Sala; Elena Laura Georgescu Margarint; Clément Léna; Daniela Popa; Jimena Laura Frontera; Andrés Pablo Varani; Fabien Menardy; Assunta Pelosi; Denis Hervé Journal: Elife Date: 2022-06-14 Impact factor: 8.713
Authors: Ikuo Masuho; Sreenivas Chavali; Brian S Muntean; Nickolas K Skamangas; Kristina Simonyan; Dipak N Patil; Grant M Kramer; Laurie Ozelius; M Madan Babu; Kirill A Martemyanov Journal: Cell Rep Date: 2018-07-17 Impact factor: 9.423